Treatment of family hypercholesterolemia with PCSK9 inhibitors: an integrative review. Research, Society and Development, [S. l.], v. 10, n. 15, p. e233101523018, 2021. DOI: 10.33448/rsd-v10i15.23018. Disponível em: https://rsdjournal.org/rsd/article/view/23018. Acesso em: 5 dec. 2025.